Countries
Institutions
Fields
Rankings
Compare

Search institutions, scholars, countries and publications

Sankore

Named after the University of Sankore in Timbuktu — one of the world’s oldest centres of learning. Every figure here is computed from work-level records in our own graph, never copied from a source’s summary count.

Built from

OpenAlex — works, authorships, subject classification
ROR — institutional identity
ORCID — researcher identity
Crossref — publisher confirmation

Browse

Countries
Institutions
Fields
Rankings
What we cover

Coverage is partial and says so. A country appears with its research output only once its works have been swept; until then the portal shows whatever the graph happens to hold for it and labels it as exactly that.

Discovery of Small Molecule PARKIN Activator from Antipsychotic/Anti-neuropsychiatric Drugs as Therapeutics for PD: an In Silico Repurposing Approach

2023Applied Biochemistry and BiotechnologyJournal

10.1007/s12010-023-04376-2 Full text17 citations

Authors

6 authors across 4 institutions in 1 country.

Abdulwasiu IbrahimFirst authorCorresponding
- Usmanu Danfodiyo University (NG)
- University of Ibadan (NG)
Nureni IpinlojuCorresponding
- Adekunle Ajasin University (NG)
Nkechi H. Atasie
as printed: Nkechi Hope Atasie
Rahmotallah Mosunmola Babalola
- University of Lagos (NG)
Suleiman A. Muhammad
as printed: Suleiman Alhaji Muhammad
Oluwatoba Emmanuel OyeneyinSenior author
- Adekunle Ajasin University (NG)

Fields

Assignment is probabilistic — a work belongs to several fields in proportions.

Computational Drug Discovery Methodslevel 3 · 1.00
Cholinesterase and Neurodegenerative Diseaseslevel 3 · 1.00
Synthesis and biological activitylevel 3 · 0.98

Sources

Several sources describing one work is the point — it means the record rests on more than one authority.

openalexseen September 9, 2026
2023 · Applied Biochemistry and Biotechnology · 17 citations
https://openalex.org/W4319057707

Discovery of Small Molecule PARKIN Activator from Antipsychotic/Anti-neuropsychiatric Drugs as Therapeutics for PD: an In Silico Repurposing Approach · Sankore